Labshake search
Citations for Bio X Cell :
651 - 700 of 709 citations for IL 1 beta Rat since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... IFNAR in vivo blocking during coinfection was performed by injecting infected mice with 500 μg of anti-IFNAR-1 (clone MAR1-5A3, from BioXcell) or isotype control antibody (clone MOPC-21 ...
-
bioRxiv - Cell Biology 2020Quote: ... mice bearing ~50mm3 tumors were randomized and treated with 200 μg of anti-PD-1 antibody (BioXcell, Clone RMP1-14) or isotype control via IP injections three times weekly for 4 doses ...
-
The skin environment controls local dendritic cell differentiation and function through innate IL-13bioRxiv - Immunology 2021Quote: ... BM donor mice were depleted of T cells by intraperitoneal injection of 200 µg InVivoMAb anti-mouse Thy-1 (Clone T24/31, BioXCell) on day −5 and −2 before BM collection ...
-
bioRxiv - Immunology 2020Quote: ... neutrophils were depleted by intraperitoneal injection of 500 μg anti-Ly6G clone 1A8 (Bio X Cell Cat# BE0075-1, RRID:AB_1107721) or rat IgG2a isotype control clone 2A3 (Bio X Cell Cat# BE0089 ...
-
bioRxiv - Immunology 2020Quote: ... CD40L blockade or iBALT depletion were achieved by the injection of 250 µg of α-CD40L (Clone: MR-1, BioXCell) or 250 µg of LTβR-Ig weekly respectively ...
-
bioRxiv - Immunology 2022Quote: Inhibition of PD-1/PD-L1 signaling was performed by intraperitoneal injection of 1mg/dose of αPD-L1 (clone: 10F.9G2, BioXcell) supplemented with 500μg/dose of polyclonal hamster IgG isotype (clone ...
-
bioRxiv - Immunology 2022Quote: ... CD4+ T cell blasts were incubated for 3 mins at room temperature with the indicated combination of the following antibodies: 1 µg/mL Armenian hamster IgG isotype control (BioXCell), 1 µg/mL anti-CD3e (145-2C11 ...
-
bioRxiv - Cancer Biology 2022Quote: ... and anti-mouse PD-1 antibodies (clone RMP1-14, 10 mg/kg, 6 doses, every 3 days) were purchased from BioXcell. All drug treatments were administered intraperitoneally (i.p.).
-
bioRxiv - Neuroscience 2024Quote: ... for 20 min at room temperature in phosphate buffer solution (pH 7.2S) combined with FcR blocking antibody (1 μg, clone 2.4G2, BioXCell; Lebanon, NH) to block nonspecific binding ...
-
bioRxiv - Immunology 2024Quote: ... Mice received 500 rads of X-ray radiation (X-Rad320, Precision X-Ray Irradiation) and 125 µg of PD-1 antibody (CD279, BioXCell) i.p ...
-
bioRxiv - Immunology 2023Quote: ... T cells reached a resting state and were restimulated at a concentration of 2×106 ml-1 for 48 h in the presence of plate-bound anti-CD3 (clone 145-2C11, BioXCell) and anti-CD28 (clone PV-1 ...
-
bioRxiv - Neuroscience 2023Quote: ... for 20 min at room temperature in phosphate buffer solution pH 7.2 (PBS) combined with FcR blocking antibody (1 μg, clone 2.4G2, BioXCell; Lebanon, NH) to block non-specific binding ...
-
bioRxiv - Immunology 2023Quote: ... They were differentiated (9) for 2 days with plate bound anti-CD3 and anti-CD28 (2 μg mL-1 each; BioXcell) into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems ...
-
bioRxiv - Immunology 2023Quote: ... Anti-PD-1 blocking and/or anti-OX40 agonist antibodies (29F.1A12 and OX-86 respectively; BioXCell,West Lebanon, NH) were administered intraperitoneally at doses of 200 μg per mouse on days 6 ...
-
bioRxiv - Immunology 2023Quote: ... cells were restimulated at a concentration of 2×106/ml for 48h in the presence of plate-bound anti-CD3 and anti-CD28 (clone PV-1; BioXCell) antibodies both at 2 µg/ml in fresh medium without any cytokines ...
-
bioRxiv - Neuroscience 2023Quote: ... for 20 min at room temperature in PBS combined with FcR blocking antibody (1 μg, clone 2.4G2, BioXCell, Missouri, TX) to block non-specific binding ...
-
bioRxiv - Cancer Biology 2023Quote: ... mice were treated intraperitoneally every 3 days with either 1 mg/kg ADU-S100 and 200 µg anti-PD1/isotype (BioXcell) or with 20 mg/kg MCC950 ...
-
bioRxiv - Immunology 2023Quote: ... Cells were washed in FACS buffer followed by surface staining for 30 min at 4°C with directly conjugated antibodies diluted in FACS buffer containing 1:100 anti-CD16/32 (Fc block; BioXCell) to block non-specific binding ...
-
bioRxiv - Immunology 2024Quote: ... cells were cultured on plates pre-coated (overnight at 4°C) with anti-CD3 (2 μg/mL; BioXcell BE0001-1) and anti-CD28 (4 μg/mL ...
-
bioRxiv - Microbiology 2021Quote: Signaling by interferon alpha receptor 1 (IFNAR1) was inhibited by treating mice with 0.05 mg anti-IFNAR1 antibody (MAR1-5A3, Bio X Cell) intranasally on days -2 and 0 with virus or mock inoculations ...
-
bioRxiv - Cancer Biology 2022Quote: ... followed by the treatment of vehicle or anti-PD-1 antibody (i.p., 200 μg/mouse, Bio X cell, clone RMP1-14) at day 0 ...
-
bioRxiv - Cell Biology 2021Quote: ... Isolated splenocytes were pooled together and placed in 24-well plates at 106 cells per ml concentration in 1.5 ml and activated with anti-CD3 mAb (145-2C11 clone, plate-bound, 1 µg/ml) and anti-CD28 mAb (37.51 clone, soluble, 2 µg/ml) from Bio X Cell in RPMI media for 48 hours with or without human (h ...
-
bioRxiv - Immunology 2020Quote: ... CD8 positive T cell depletion was achieved using 250 μg InVivoMab anti-mouse CD8α antibody (clone 53-6.7, BioXCell, BE0004-1) or IgG2a control (BioXCell ...
-
bioRxiv - Immunology 2020Quote: ... Inhibition of PD-1/PD-L1 signaling was performed by intraperitoneal injection of 1mg of α-PD-L1 (clone: 10F.9G2, BioXcell), while control mice were treated with the IgG2b isotype (clone ...
-
bioRxiv - Neuroscience 2022Quote: ... each mouse received retro-orbital or intraperitoneal (i.p.) injection of 100 μg anti-mouse Ly6G IgG (BE0075-1; Bio X Cell) or isotype-matched IgG2a (BE0089 ...
-
bioRxiv - Immunology 2023Quote: ... 2×106 cells were activated with 0.5 μg/ml of anti-CD3 (clone 145-2C1) together with 1 μg/ml anti-CD28 (clone 37.51, both Bio X Cell). After 2 days of activation ...
-
bioRxiv - Immunology 2023Quote: ... or with 1 μg/ml of anti-CD3 (clone 145-2C1) together with 1 μg/ml anti-CD28 (clone 37.51, both Bio X Cell) in the presence of 2 μg/ml brefeldin A and 2 μM monensin (both eBioscience ...
-
bioRxiv - Immunology 2023Quote: ... 2-DG-treated and control P14 T cells were activated with 0.5 μg/ml of anti-CD3 (clone 145-2C1) and 1 μg/ml anti-CD28 (clone 37.51, both Bio X Cell) in presence of 10 ng/ml rhIL-2 (Peprotech ...
-
bioRxiv - Immunology 2023Quote: ... LCMV-NP (self-conjugated to AF488 using Thermo Fisher AF488 labeling kit per manufacturer’s instructions, BioXcell, 1:50, clone VL-4).
-
bioRxiv - Immunology 2023Quote: ... Mice received intraperitoneal doses of anti–PD-1 antibody (200 μg/100 μL; clone RMP1-14; cat. #BE0146; Bio X Cell) or anti-CTLA-4 (200 μg/100 μL ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2024Quote: Endogenous macrophages or CD4+ T cells were depleted by injecting PLX3397 (S7818, Selleck, USA), clodronate liposomes (40337ES08, YEASEN, China) or anti-CD4 antibody (BE0003-1, BioXcell, USA) intraperitoneally every three days starting from day 10.5 of gestation.
-
bioRxiv - Immunology 2019Quote: The common in vitro activation protocol for activation of CD4+ T cells was followed by culturing 1×106 cells/mL in tissue culture-treated 24-well plates that were pre-coated with anti-CD3 (2C11; Bio X Cell) at a concentration of 10 μg/mL followed by addition of 2 μg/mL soluble anti-CD28 (37.51 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Mice were randomly assigned to two groups treated with control IgG or anti-PD-1 monoclonal antibody (ip. 200 μg/mouse, clone RMP1-14, Bio X cell) at day 0 ...
-
bioRxiv - Immunology 2019Quote: ... For Th2 induction 1×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell) and αCD28 (10 μg mL−1 ...
-
bioRxiv - Immunology 2019Quote: ... 2 to 3×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell), αCD28 (1 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... tumor-bearing mice received intraperitoneal injections of 200 µg of 1A8 (Ly6g depletion, BE0075-1) or 2A3 (control; BE0089, both from Bio X Cell) antibody per mouse starting from day 25 after DF1 cell injection ...
-
bioRxiv - Neuroscience 2024Quote: ... 106 naïve CD8+ T cells were seeded on CD3-coated wells and anti-CD28 antibody (BioXcell, clone 37-51; cat # BE0015-1) was added to reach a final concentration of 5 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... 100 µg of CD4 and 100 µg of CD8 depleting antibodies were injected intraperitoneally in 100 µL sterile PBS per mouse 24 hours before challenge infection. 100 µg (Fig. 1) or 200 µg of the isotype control (Fig. 6) (clone LTF-2, Bio X Cell) were injected intraperitoneally in 100 µL of sterile PBS per mouse at the same time in control groups.
-
bioRxiv - Cancer Biology 2023Quote: ... were injected intraperitoneally with monoclonal antibodies against PD-1 (RMP1-14, 250 μg per dose) and CLTA-4 (9D9, 100 μg per dose) (BioXCell, Lebanon, NH) in sterile PBS or a control PBS solution (25) ...
-
bioRxiv - Immunology 2023Quote: ... CD4+ T cells were depleted in male and female mice by intraperitoneally injecting mice with 200 μg of an anti-CD4 antibody (anti-mouse CD4 clone: GK1.5, BioXcell, catalog # BE0003-1). A group of mice receiving an intraperitoneal injection of an isotype control antibody (rat IgG2b LTF-2 ...
-
bioRxiv - Cancer Biology 2019Quote: ... TAM-treated K14CreERT;Ptchf/f mice were intraperitoneally injected every third day for 5 weeks with 250 µg of anti-PD-1 blocking antibodies (clone RMP1-14, BioXCell, West Lebanon, NH), according to previously published papers (Curran et al. ...
-
bioRxiv - Immunology 2020Quote: ... To deplete T cell populations BALB/c mice received one intraperitoneal injection of 500 µg of anti-mouse CD4 (BE0003-1, BioXCell, West Lebanon, NH) and 500 µg of anti-mouse CD8α (BioXCell ...
-
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccinesbioRxiv - Cancer Biology 2021Quote: MHC class I peptides were immunoaffinity purified from the CT26 mouse cell line using anti-mouse MHC class I (clone 34-1-2S, BioXcell, BE0180 Lebanon, USA). For sample preparation ...
-
bioRxiv - Immunology 2022Quote: ... splenocytes were isolated from 18-day infected mice and stimulated with plate-bound anti-CD3ε (Clone 145-2C11, 2 μg/mL) and soluble αCD28 (Clone 37.51, 1 μg/mL) (both from BioXcell, West Lebanon, NH, USA) for 6 h ...
-
Versatile and Robust method for Antibody Conjugation to Nanoparticles with High Targeting EfficiencybioRxiv - Biochemistry 2021Quote: Anti-human EGFR (αEGFR, monoclonal, cat. BE0278) and anti-human CD44 (αCD44, monoclonal, hermes-1, cat. BE0039) were purchased from Bio X Cell (Lebanon). Tetraethyl orthosilicate (TEOS ...
-
bioRxiv - Immunology 2021Quote: ... – and in vivo ICI treatment – anti-mouse PD-1 (RMP1-14) and anti-mouse CTLA-4 (9D9) – were purchased from Bio X Cell (USA). For T cell depletion ...
-
bioRxiv - Cell Biology 2024Quote: ... 1 × 105 target cells were added to the 24-well BMDM plate and incubated with 1 mg/mL anti-mouse Isotype or anti-CD47 antibodies (BioXCell BE0083 and BE02830). After 2 h ...
-
bioRxiv - Cancer Biology 2024Quote: ... Cells were treated with anti-CD38 (Novus, NIMR-5) 1 μg/mL or isotype control IgG2a (Bio X Cell, 2A3, 10 μg/mL) for 3 days and were analysed using flow cytometry.